Clinical Trials Logo

Epigastric Pain Syndrome clinical trials

View clinical trials related to Epigastric Pain Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT00673972 Withdrawn - Clinical trials for Functional Dyspepsia

Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome

Start date: April 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare postprandial distress syndrome and epigastric pain syndrome in demographics psychological features, infection of Helicobacter pylori, gastric emptying and therapeutic response to lansoprazole.

NCT ID: NCT00663897 Completed - Clinical trials for Functional Dyspepsia

Lansoprazole Versus Mosapride for Functional Dyspepsia

Start date: May 2008
Phase: Phase 4
Study type: Interventional

Functional dyspepsia is a common symptom complex with significant impact on quality of life. There is no standard treatment for functional dyspepsia but therapeutic efficacy of proton pump inhibitor (PPI) and prokinetic agent have been proved in subsets of patients. This study has two aims: - first is to compare the therapeutic efficacy of lansoprazole (a PPI) and mosapride (a prokinetic agent) for functional dyspepsia - second is to investigate whether different subgroups of functional dyspepsia (e.g., epigastric pain syndrome and postprandial distress syndrome) respond differently to PPI and prokinetic agent.